美国华盛顿州生物技术、生物医学协会主席克里斯•瑞维拉

Chris E. Rivera, President of Washington Biotechnology & Biomedical Association

Rivera is President of Washington Biotechnology & Biomedical Association. He was the founder and CEO of Hyperion Therapeutics, a specialty biopharmaceutical company focused in the development and commercialization of therapies for gastroenterology and hepatology diseases. Prior to starting Hyperion, he was Senior President of Commercial Operations at Tercica, Inc., where he was responsible for developing and overseeing Tercica’s global commercialization strategies and was intimately involved in the development and consummation of an international cross-licensing collaboration with Ipsen. As Senior Vice President of Genzyme. Therapeutics, Rivera was largely responsible for building the company’s U.S. renal division and assisted in the launch of Renagel (sevelamer hydrochloride) globally.

Rivera holds a Master of Science degree in Audiology from the University of Oklahoma Health Sciences Center; a Bachelor of Science degree in Business from Northwestern Oklahoma State University; and studied Marketing and Management at the Albers Graduate School of Business and Economics at Seattle University.

Chris E. Rivera will make speech at Development of High-tech Enterprises International Forums.

克里斯•瑞维拉先生是华盛顿州生物技术、生物医学协会主席，华盛顿技术联盟主席，华盛顿州生命科学专家和领军人物，并任沃顿商学院生物技术学院院长。

克里斯•瑞维拉先生拥有20年在生物技术，制药和保健领域的领导管理经验，致力于美国生物技术，生物医学的整体发展和胰岛素样生长因子的全球战略研究。此外，他还多次代表美国出席重大会议，曾出席第九届雷曼兄弟全球卫生保健年度会议等。华盛顿大学MBA，美国东北奥克拉荷马州立大学和美国俄克拉荷马大学理科硕士，并荣获“助残贡献奖”。

克里斯•瑞维拉先生将在本届科博会中国高新企业发展国际论坛发表演讲.